Table 2.

Salvage therapy

TherapyNumber of subjects who entered follow-up phase (%)
Radiotherapy only (n = 282)Radiotherapy + temozolomide (n = 277)
Any therapy195 (69.1)146 (52.7)
Temozolomide161 (57.1)62 (22.4)
Lomustine40 (14.2)44 (15.9)
Procarbazine24 (8.5)21 (7.6)
Vincristine23 (8.2)22 (7.9)
Carmustine18 (6.4)23 (8.3)
Other cancer drug therapies98 (34.8)113 (40.8)
Surgery13 (4.6)21 (7.6)